Advertisement
Home Tags Liver Disease: Misc.

Tag: Liver Disease: Misc.

A novel non-elective inpatient hepatology rotation increases knowledge of chronic liver disease among internal medicine residents

Novel Hepatology Rotation Ups Knowledge of Liver Disease

0
Significant increase in mean comfort level for managing several common liver diseases
For patients with primary biliary cholangitis

Obeticholic Acid Beneficial in Primary Biliary Cholangitis

0
Obeticholic acid linked to decrease in alkaline phosphatase and total bilirubin levels
For liver transplant recipients

Liver Steatosis Ups New-Onset Diabetes After Transplantation

0
Donor liver steatosis is independent risk factor for NODAT among liver transplant recipients
A new proposal would mean where Americans live will no longer affect how long they have to wait for a liver transplant.

Proposed Change Could Improve Liver Transplant Access

0
New distribution system would enable wider sharing of donated livers
Obstructive sleep apnea/hypoxia is associated with progression of nonalcoholic steatohepatitis in pediatric patients with nonalcoholic fatty liver disease

Night Hypoxia Tied to Progression of Peds Liver Disease

0
More severe fibrosis for patients with obstructive sleep apnea/hypoxia versus those without
The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus.

FDA Approves Epclusa for Chronic Hepatitis C

0
Combination drug treats six major strains of hepatitis C virus infection
Alanine aminotransferase levels within normal range are associated with cardiovascular event risk

ALT Levels Within Normal Range Linked to Cardiovascular Events

0
Incident cardiovascular events were highest for those in the lowest tertile of baseline ALT
For patients with prediabetes or type 2 diabetes mellitus and nonalcoholic steatohepatitis

Long-Term Pioglitazone Safe, Effective for NASH, T2DM

0
Safe and effective for patients with prediabetes or type 2 diabetes and nonalcoholic steatohepatitis
Older teen boys who are overweight or obese could be at increased risk for severe liver disease later in life

Obesity in Older Male Teens Ups Risk for Liver Disease Later

0
Researchers find odds increase as weight goes up
Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with inadequate response to UDCA

FDA Approves Ocaliva for Primary Biliary Cholangitis

0
For patients who have not responded to, or cannot tolerate, ursodeoxycholic acid